RNA thiolation level (incorporation of methionine-S35) in peripheral lymphocytes of donors and patients with chronic lymphatic leukemia

1973 ◽  
Vol 76 (6) ◽  
pp. 1430-1431
Author(s):  
N. A. Fedorov ◽  
N. V. Biryukova ◽  
R. �. Kimeral
Keyword(s):  
Chronic Lymphatic Leukemia ◽  
Peripheral Lymphocytes ◽  
Lymphatic Leukemia

scholarly journals TWO DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES

1973 ◽  
Vol 138 (4) ◽  
pp. 798-811 ◽  
Author(s):  
Gordon D. Ross ◽  
Margaret J. Polley ◽  
Enrique M. Rabellino ◽  
Howard M. Grey
Keyword(s):  
Peripheral Blood ◽  
Human Lymphocytes ◽  
The Other ◽  
Complement Receptors ◽  
Chronic Lymphatic Leukemia ◽  
Lymphoblastoid Cells ◽  
Normal Peripheral Blood ◽  
Peripheral Lymphocytes ◽  
Immune Adherence ◽  
Lymphatic Leukemia

In the present study it was shown that normal peripheral lymphocytes have two different complement receptors: one for C3b (the immune adherence receptor) and one for C3b subsequent to its cleavage by C3b inactivator. The two receptors are not cross-reactive and were shown by tests with various antisera to be antigenically distinct. Both the immune adherence receptor and the receptor for C3b inactivator-cleaved C3b were found on normal peripheral lymphocytes and on cultured lymphoblastoid cells. In 15 out of 18 chronic lymphatic leukemia patients, the immune adherence receptor was either partially or completely missing from the peripheral lymphocytes, while the lymphocyte receptor for C3b inactivator-cleaved C3b was retained. Normal erythrocytes, on the other hand, were found to have only the immune adherence receptor. Granulocytes from normal peripheral blood appeared to have only a receptor for C3b and did not have a receptor for C3b inactivator-cleaved C3b.

Acute Lymphoblastic Crisis in a Patient with Chronic Lymphatic Leukemia

1975 ◽  
Vol 54 (5) ◽  
pp. 306-311 ◽  
Author(s):  
A. Klajman ◽  
A. Yaretzky ◽  
J. Manor ◽  
Z. Steiner
Keyword(s):  
Chronic Lymphatic Leukemia ◽  
Lymphatic Leukemia

scholarly journals A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia

Leukemia ◽  
2000 ◽  
Vol 14 (4) ◽  
pp. 754-766 ◽  
Author(s):  
T Pfitzner ◽  
A Engert ◽  
H Wittor ◽  
T Schinköthe ◽  
F Oberhäuser ◽  
...  
Keyword(s):  
B Cell ◽  
Real Time ◽  
Real Time Pcr ◽  
Malignant Cells ◽  
Chronic Lymphatic Leukemia ◽  
Pcr Assay ◽  
Lymphatic Leukemia

Use of immunocorrectors in patients with chronic lymph leukemia

1986 ◽  
Vol 67 (2) ◽  
pp. 99-101
Author(s):  
V. Ya. Shustov ◽  
N. A. Afanasyeva ◽  
P. P. Kuznetsov ◽  
A. K. Myshkina
Keyword(s):  
Immune System ◽  
Outpatient Treatment ◽  
Infectious Complications ◽  
Chronic Lymphatic Leukemia ◽  
Cytostatic Drugs ◽  
Ability To Work ◽  
Lymphatic Leukemia ◽  
Long Time ◽  
Negative Effect

Chronic lymphatic leukemia is second only to acute leukemia in the frequency of infectious complications. In most cases, severe infectious complications are the cause of death in these patients. Modern chemotherapy makes it possible to preserve the ability to work and the life expectancy of patients for a long time. However, the negative effect of cytostatic drugs on the already altered immune system leads to an even greater suppression of immunity and an increase in the number of infectious complications. The search for new ways to combat infections has shown the advisability of long-term outpatient treatment with antibacterial drugs.

Membrane markers, karyotypic abnormalities, ultrastructure and functional properties of lymphocytes in a case of ‘D-cell’ chronic lymphatic leukemia

1984 ◽  
Vol 8 (2) ◽  
pp. 223-237
Author(s):  
Jean-Pierre Bergerat ◽  
Jean-Marie Lang ◽  
Salomon Levy ◽  
Marie-Marthe Tongio ◽  
Francoise Uettwiller ◽  
...  
Keyword(s):  
Functional Properties ◽  
Chronic Lymphatic Leukemia ◽  
Membrane Markers ◽  
Lymphatic Leukemia ◽  
D Cell
Sign in / Sign up

Export Citation Format

Share Document